208 related articles for article (PubMed ID: 35771747)
1. Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
Meng X; Wang L; He M; Yang Z; Jiao Y; Hu Y; Wang K
PLoS One; 2022; 17(6):e0269998. PubMed ID: 35771747
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
PeerJ; 2023; 11():e15654. PubMed ID: 37520246
[TBL] [Abstract][Full Text] [Related]
3. A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
Cui Y; Jiao Y; Wang K; He M; Yang Z
Cancer Genet; 2019 Nov; 239():54-61. PubMed ID: 31561066
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine aminotransferase 3/glutamine transaminase L/cysteine conjugate beta-lyase 2 is a major glutamine transaminase in the mouse kidney.
Yang C; Zhang L; Han Q; Liao C; Lan J; Ding H; Zhou H; Diao X; Li J
Biochem Biophys Rep; 2016 Dec; 8():234-241. PubMed ID: 28955961
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
6. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
Zhao W; Chang Y; Wu Z; Jiang X; Li Y; Xie R; Fu D; Sun C; Gao J
PeerJ; 2023; 11():e15703. PubMed ID: 37483962
[TBL] [Abstract][Full Text] [Related]
7. Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer.
Yan N; Liu C; Tian F; Wang L; Wang Y; Yang Z; Jiao Y; He M
Int J Genomics; 2021; 2021():4301802. PubMed ID: 33614780
[TBL] [Abstract][Full Text] [Related]
8. The clinical and genetic features in patients coexisting primary breast and thyroid cancers.
Fu J; He M; Wu Q; Zhang X; Qi X; Shen K; Wang X; Zhang G
Front Endocrinol (Lausanne); 2023; 14():1136120. PubMed ID: 37229458
[TBL] [Abstract][Full Text] [Related]
9. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
12. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
14. Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
Hao R; Liu Y; Du Q; Liu L; Chen S; You H; Dong Y
Breast Cancer; 2019 Nov; 26(6):776-783. PubMed ID: 31144206
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HMGB3 and its prognostic value in breast cancer.
Zhou X; Zhang Q; Liang G; Liang X; Luo B
Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
[TBL] [Abstract][Full Text] [Related]
16. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
17. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA LINC01614 is a Diagnostic and Prognostic Marker for Breast Cancer.
Li W; Cheng Y; Cheng J; Yao J; Song M; Yan M; Qi Y
Discov Med; 2023 Feb; 35(174):19-27. PubMed ID: 37024438
[TBL] [Abstract][Full Text] [Related]
19. Reduced Expression of KRT17 Predicts Poor Prognosis in HER2
Tang S; Liu W; Yong L; Liu D; Lin X; Huang Y; Wang H; Cai F
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139022
[TBL] [Abstract][Full Text] [Related]
20. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
